Research statistics
Lanreotide research: publications and trials
At a glance
Publications, all years
1,279
Since 1988
Publications in 2026 so far
37
Through November 15, 2026
Human clinical research
56.1%
711 of 1,267 classified
Registered clinical trials
84
ClinicalTrials.gov
Randomized controlled trials
86
Publications reporting an RCT in people
Systematic reviews and meta-analyses
38
Preclinical studies
17.0%
113 animal · 79 in vitro · 23 computational
Records that only mention it
250
Not counted above
Status in the library: FDA-approved. 12 publications are not yet classified by study type.
What to keep in mind
- Some completed trials have neither posted results nor a linked results publication.
Publications by year
Lanreotide publications by year and evidence
Show the data
| Year | Human clinical research | Preclinical (animal, in vitro, computational) | Reviews and meta-analyses | Other and not yet classified | Total |
|---|---|---|---|---|---|
| 1988 | 0 | 1 | 0 | 0 | 1 |
| 1989 | 1 | 7 | 0 | 1 | 9 |
| 1990 | 0 | 2 | 0 | 1 | 3 |
| 1991 | 1 | 6 | 1 | 0 | 8 |
| 1992 | 4 | 4 | 0 | 3 | 11 |
| 1993 | 7 | 14 | 4 | 0 | 25 |
| 1994 | 12 | 11 | 1 | 2 | 26 |
| 1995 | 14 | 9 | 3 | 1 | 27 |
| 1996 | 13 | 8 | 8 | 1 | 30 |
| 1997 | 10 | 11 | 4 | 3 | 28 |
| 1998 | 8 | 5 | 2 | 0 | 15 |
| 1999 | 32 | 6 | 6 | 1 | 45 |
| 2000 | 26 | 4 | 9 | 3 | 42 |
| 2001 | 18 | 8 | 12 | 2 | 40 |
| 2002 | 26 | 6 | 19 | 1 | 52 |
| 2003 | 16 | 4 | 18 | 2 | 40 |
| 2004 | 21 | 3 | 9 | 2 | 35 |
| 2005 | 20 | 3 | 11 | 0 | 34 |
| 2006 | 15 | 5 | 13 | 0 | 33 |
| 2007 | 19 | 5 | 4 | 3 | 31 |
| 2008 | 19 | 10 | 12 | 3 | 44 |
| 2009 | 15 | 3 | 8 | 1 | 27 |
| 2010 | 18 | 4 | 12 | 3 | 37 |
| 2011 | 12 | 4 | 9 | 1 | 26 |
| 2012 | 25 | 5 | 7 | 2 | 39 |
| 2013 | 15 | 5 | 8 | 1 | 29 |
| 2014 | 17 | 5 | 19 | 8 | 49 |
| 2015 | 21 | 1 | 16 | 0 | 38 |
| 2016 | 27 | 2 | 18 | 1 | 48 |
| 2017 | 27 | 7 | 12 | 2 | 48 |
| 2018 | 27 | 2 | 7 | 0 | 36 |
| 2019 | 28 | 6 | 8 | 1 | 43 |
| 2020 | 39 | 7 | 5 | 2 | 53 |
| 2021 | 29 | 3 | 4 | 0 | 36 |
| 2022 | 23 | 5 | 4 | 1 | 33 |
| 2023 | 18 | 0 | 3 | 0 | 21 |
| 2024 | 36 | 9 | 8 | 1 | 54 |
| 2025 | 30 | 10 | 5 | 1 | 46 |
| 2026 (to date) | 22 | 5 | 7 | 3 | 37 |
Study types
| Review | 258 |
|---|---|
| Case report | 245 |
| Observational human study | 193 |
| Other clinical trial | 187 |
| Animal study | 113 |
| Randomized controlled trial | 86 |
| In vitro study | 79 |
| Editorial, letter or other | 41 |
| Computational study | 23 |
| Meta-analysis | 19 |
| Systematic review | 19 |
| Not yet classified | 12 |
| Guideline or consensus | 4 |
Research areas
From MeSH major topics. A paper can be in several areas.
| Oncology | 771 |
|---|---|
| Endocrinology | 708 |
| Neurological and mental health | 415 |
| Gastrointestinal | 342 |
| Musculoskeletal | 325 |
| Cardiovascular | 121 |
| Metabolic health | 83 |
| Reproductive and sexual health | 69 |
| Immune system | 52 |
| Dermatology | 29 |
| Antimicrobial and infectious disease | 14 |
| Tissue repair | 13 |
Registered clinical trials
10 of 49 trials completed at least a year before the cutoff have neither posted results nor a linked results publication. A registration is not a result.
Completed: 52 · Terminated: 12 · Unknown status: 10 · Recruiting: 5 · Active, not recruiting: 3 · Withdrawn: 2
Early phase 1: 1 · Phase not applicable: 10 · Phase 1: 1 · Phase 1 / Phase 2: 3 · Phase 2: 21 · Phase 2 / Phase 3: 7 · Phase 3: 28 · Phase 4: 13
The 50 most recently started of 84 trials.
Human trials and evidence reviews
Meta-analyses, systematic reviews and trials in people, newest first.
- Comparative Efficacy and Safety of Octreotide, Lanreotide, and Pasireotide in Autosomal Dominant Polycystic Kidney Disease and Polycystic Liver Disease: A Network Meta-Analysis With Real-World Evidence From the FDA Adverse Event Reporting System Database.
Clinical and translational gastroenterology · July 20, 2026 · Meta-analysis · cited 0 times · open access
PMID 42476150 · DOI 10.14309/ctg.0000000000001076 · Reviews and meta-analyses
- Somatostatin-based therapies for external gastrointestinal fistulas: Updated meta-analysis of randomized clinical trials.
World journal of gastrointestinal pharmacology and therapeutics · December 1, 2025 · Meta-analysis · cited 1 times · open access
PMID 41378069 · DOI 10.4292/wjgpt.v16.i4.111889 · Reviews and meta-analyses
- Effectiveness and predictors of response to somatostatin analogues in patients with gastrointestinal angiodysplasias: a systematic review and individual patient data meta-analysis.
The lancet. Gastroenterology & hepatology · September 9, 2021 · Meta-analysis · cited 53 times
PMID 34508668 · DOI 10.1016/s2468-1253(21)00262-4 · Reviews and meta-analyses
- Multivariable Prediction Model for Biochemical Response to First-Generation Somatostatin Receptor Ligands in Acromegaly.
The Journal of clinical endocrinology and metabolism · September 1, 2020 · Meta-analysis · cited 53 times · open access
PMID 32589751 · DOI 10.1210/clinem/dgaa387 · Reviews and meta-analyses
- Response and relapse rates after treatment with long-acting somatostatin analogs in multifocal or recurrent type-1 gastric carcinoids: A systematic review and meta-analysis.
United European gastroenterology journal · November 22, 2019 · Meta-analysis · cited 31 times · open access
PMID 32213066 · DOI 10.1177/2050640619890465 · Reviews and meta-analyses
- Meta-Analysis of Randomized Clinical Trials Comparing Active Treatment with Placebo in Metastatic Neuroendocrine Tumors.
The oncologist · July 22, 2019 · Meta-analysis · cited 10 times · open access
PMID 31332100 · DOI 10.1634/theoncologist.2018-0675 · Reviews and meta-analyses
- Pegvisomant Improves Glucose Metabolism in Acromegaly: A Meta-Analysis of Prospective Interventional Studies.
The Journal of clinical endocrinology and metabolism · July 1, 2019 · Meta-analysis · cited 80 times · open access
PMID 30869797 · DOI 10.1210/jc.2018-02281 · Reviews and meta-analyses
- Management of carcinoid syndrome: a systematic review and meta-analysis.
Endocrine-related cancer · March 1, 2019 · Meta-analysis · cited 87 times · open access
PMID 30608900 · DOI 10.1530/erc-18-0495 · Reviews and meta-analyses
- Somatostatin Analogs and Glucose Metabolism in Acromegaly: A Meta-analysis of Prospective Interventional Studies.
The Journal of clinical endocrinology and metabolism · March 23, 2018 · Meta-analysis · cited 67 times
PMID 29590371 · DOI 10.1210/jc.2017-02566 · Reviews and meta-analyses
- Preoperative somatostatin analogues versus direct transsphenoidal surgery for newly-diagnosed acromegaly patients: a systematic review and meta-analysis using the GRADE system.
Pituitary · August 1, 2015 · Meta-analysis · cited 50 times
PMID 25261979 · DOI 10.1007/s11102-014-0602-9 · Reviews and meta-analyses
Most cited
By OpenAlex citation count. Citations measure attention, not quality or correctness.
- Lanreotide in metastatic enteropancreatic neuroendocrine tumors.
The New England journal of medicine · July 1, 2014 · Randomized controlled trial · cited 1,942 times · open access
PMID 25014687 · DOI 10.1056/nejmoa1316158 · Human clinical research
- Affinity profiles for human somatostatin receptor subtypes SST1-SST5 of somatostatin radiotracers selected for scintigraphic and radiotherapeutic use.
European journal of nuclear medicine · March 1, 2000 · In vitro study · cited 1,124 times
PMID 10774879 · DOI 10.1007/s002590050034 · In vitro studies
- Consensus report on the use of somatostatin analogs for the management of neuroendocrine tumors of the gastroenteropancreatic system.
Annals of oncology : official journal of the European Society for Medical Oncology · June 1, 2004 · Review · cited 578 times · open access
PMID 15151956 · DOI 10.1093/annonc/mdh216 · Reviews and meta-analyses
- Classification and nomenclature of somatostatin receptors.
Trends in pharmacological sciences · March 1, 1995 · Review · cited 572 times · open access
PMID 7792934 · DOI 10.1016/s0165-6147(00)88988-9 · Reviews and meta-analyses
- Involvement of the low-density lipoprotein receptor-related protein in the transcytosis of the brain delivery vector angiopep-2.
Journal of neurochemistry · May 19, 2008 · In vitro study · cited 556 times
PMID 18489712 · DOI 10.1111/j.1471-4159.2008.05492.x · In vitro studies
Latest publications
- Recurrent Hypertensive Carcinoid Crisis Despite Somatostatin Analog Therapy.
Cureus · November 12, 2026 · Case report · cited 0 times · open access
PMID 43022911 · DOI 10.7759/cureus.119532 · Human clinical research
- A phase I/II study using cabozantinib and lanreotide as treatments for advanced GEP-NETs for which molecular targeted therapy or chemotherapy have failed (SCALET): TCOG T2221 study.
ESMO open · November 3, 2026 · Other clinical trial · cited 0 times
PMID 42976416 · DOI 10.1016/j.esmoop.2026.108618 · Human clinical research
- Somatostatin analogues for ADPKD: ending the confusing story of mGFR and eGFR.
Kidney international · October 1, 2026 · Editorial, letter or other · cited 0 times · open access
PMID 42760021 · DOI 10.1016/j.kint.2026.07.004 · Commentary and other
- Lanreotide, a Somatostatin Analogue, in Advanced Merkel Cell Carcinoma: A Prospective Single-Arm Phase II Study.
Cancer medicine · October 1, 2026 · Other clinical trial · cited 0 times · open access
PMID 42791653 · DOI 10.1002/cam4.72295 · Human clinical research
- Endoscopic transsphenoidal surgery for a somatotroph pituitary neuroendocrine tumor associated with an infraoptic course of the anterior cerebral artery: A case report.
Surgical neurology international · September 18, 2026 · Case report · cited 0 times · open access
PMID 42829594 · DOI 10.25259/sni_840_2026 · Human clinical research
- Lanreotide
September 15, 2026 · Review · cited 0 times · open access
PMID 31145576 · Reviews and meta-analyses
- Pregnancy in a patient with metastatic functioning midgut neuroendocrine tumor receiving lanreotide after peptide receptor radionuclide therapy.
Archives of endocrinology and metabolism · September 10, 2026 · Case report · cited 0 times · open access
PMID 42721062 · DOI 10.20945/2359-4292-2026-0102 · Human clinical research
- Targeting autolysin ATL of Streptococcus suis: structural insights and inhibition by lanreotide acetate.
The Journal of antimicrobial chemotherapy · September 1, 2026 · Animal study · cited 0 times
PMID 42770615 · DOI 10.1093/jac/dkag326 · Animal studies
- Thyroid-stimulating hormone-secreting pituitary neuroendocrine tumor (TSH-PitNet) diagnosed during pregnancy and treated with a somatostatin analog.
Taiwanese journal of obstetrics & gynecology · September 1, 2026 · Case report · cited 0 times · open access
PMID 42642161 · DOI 10.1016/j.tjog.2026.03.026 · Human clinical research
- Carcinoid Heart Disease Presenting as Cardiogenic Shock: A Case Report.
Cureus · August 27, 2026 · Case report · cited 0 times · open access
PMID 42801165 · DOI 10.7759/cureus.115309 · Human clinical research
How this is counted
PubMed records matched by the names below, counted when the peptide is in the title, indexed by MeSH, or confirmed from the abstract. The exact query can be rerun on Europe PMC. Methodology
Search terms: BIM-23014; Ipstyl; Lanreotida; Lanreotide; Lanreotidum; Somatulin; Somatulina; Somatuline Autogel; Somatuline Depot
((TITLE_ABS:"BIM-23014" OR CHEM:"BIM-23014" OR TITLE_ABS:"BIM23014" OR CHEM:"BIM23014") OR (TITLE_ABS:"Ipstyl" OR CHEM:"Ipstyl") OR (TITLE_ABS:"Lanreotida" OR CHEM:"Lanreotida") OR (TITLE_ABS:"Lanreotide" OR CHEM:"Lanreotide") OR (TITLE_ABS:"Lanreotidum" OR CHEM:"Lanreotidum") OR (TITLE_ABS:"Somatulin" OR CHEM:"Somatulin") OR (TITLE_ABS:"Somatulina" OR CHEM:"Somatulina") OR (TITLE_ABS:"Somatuline Autogel" OR CHEM:"Somatuline Autogel") OR (TITLE_ABS:"Somatuline Depot" OR CHEM:"Somatuline Depot")) AND SRC:MED
Cite this page
Peptide Library. (2026, November 16). Lanreotide research statistics (Version weekly-2026-11-15) [Statistic]. Peptide Library. https://peptidelibrary.app/research/peptides/lanreotide